Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Reiner

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Chemical Biology & Drug Design|October 30, 2019
In silico and in vitro studies of two non-imidazole multiple targeting agents at histamine H<sub>3</sub> receptors and cholinesterase enzymesNakisa Ghamari, Siavoush Dastmalchi, Omid Zarei, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 25, 2024
Histamine H<sub>3</sub> receptor antagonist/nitric oxide donors as novel promising therapeutic hybrid-tools for glaucoma and retinal neuroprotectionSilvia Sgambellone, Mohammad A Khanfar, Silvia Marri, et al.
Critical Reviews in Clinical Laboratory Sciences|August 9, 2024
G protein-coupled receptor (GPCR) pharmacogenomicsMiles D Thompson, David Reiner-Link, Alessandro Berghella, et al.
International Journal of Molecular Sciences|May 16, 2020
Dual Target Ligands with 4-<i>tert-</i>Butylphenoxy Scaffold as Histamine H<sub>3</sub> Receptor Antagonists and Monoamine Oxidase B InhibitorsDorota Łażewska, Agnieszka Olejarz-Maciej, David Reiner, et al.
Chemico-Biological Interactions|August 2, 2019
The dual-active histamine H3 receptor antagonist and acetylcholine esterase inhibitor E100 ameliorates stereotyped repetitive behavior and neuroinflammmation in sodium valproate induced autism in miceNermin Eissa, Sheikh Azimullah, Petrilla Jayaprakash, et al.
International Journal of Molecular Sciences|June 7, 2020
The Dual-Active Histamine H<sub>3</sub> Receptor Antagonist and Acetylcholine Esterase Inhibitor E100 Alleviates Autistic-Like Behaviors and Oxidative Stress in Valproic Acid Induced Autism in MiceNermin Eissa, Sheikh Azimullah, Petrilla Jayaprakash, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|February 15, 2023
Novel benzothiazole derivatives as multitargeted-directed ligands for the treatment of Alzheimer's diseaseDonia E Hafez, Mariam Dubiel, Gabriella La Spada, et al.
European Journal of Pharmacology|October 5, 2020
Eosinophils adhesion assay as a tool for phenotypic drug screening - The pharmacology of 1,3,5 - Triazine and 1H-indole like derivatives against the human histamine H<sub>4</sub> receptorMarek Grosicki, Maristella Adami, Cristina Micheloni, et al.
Bioorganic & Medicinal Chemistry|April 24, 2018
Novel naphthyloxy derivatives - Potent histamine H<sub>3</sub> receptor ligands. Synthesis and pharmacological evaluationDorota Łażewska, Maria Kaleta, Stefanie Hagenow, et al.
Molecules (Basel, Switzerland)|July 2, 2021
Biphenylalkoxyamine Derivatives-Histamine H<sub>3</sub> Receptor Ligands with Butyrylcholinesterase Inhibitory ActivityDorota Łażewska, Paula Zaręba, Justyna Godyń, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Chemical Biology & Drug Design|October 30, 2019
In silico and in vitro studies of two non-imidazole multiple targeting agents at histamine H<sub>3</sub> receptors and cholinesterase enzymesNakisa Ghamari, Siavoush Dastmalchi, Omid Zarei, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 25, 2024
Histamine H<sub>3</sub> receptor antagonist/nitric oxide donors as novel promising therapeutic hybrid-tools for glaucoma and retinal neuroprotectionSilvia Sgambellone, Mohammad A Khanfar, Silvia Marri, et al.
Critical Reviews in Clinical Laboratory Sciences|August 9, 2024
G protein-coupled receptor (GPCR) pharmacogenomicsMiles D Thompson, David Reiner-Link, Alessandro Berghella, et al.
International Journal of Molecular Sciences|May 16, 2020
Dual Target Ligands with 4-<i>tert-</i>Butylphenoxy Scaffold as Histamine H<sub>3</sub> Receptor Antagonists and Monoamine Oxidase B InhibitorsDorota Łażewska, Agnieszka Olejarz-Maciej, David Reiner, et al.
Chemico-Biological Interactions|August 2, 2019
The dual-active histamine H3 receptor antagonist and acetylcholine esterase inhibitor E100 ameliorates stereotyped repetitive behavior and neuroinflammmation in sodium valproate induced autism in miceNermin Eissa, Sheikh Azimullah, Petrilla Jayaprakash, et al.
International Journal of Molecular Sciences|June 7, 2020
The Dual-Active Histamine H<sub>3</sub> Receptor Antagonist and Acetylcholine Esterase Inhibitor E100 Alleviates Autistic-Like Behaviors and Oxidative Stress in Valproic Acid Induced Autism in MiceNermin Eissa, Sheikh Azimullah, Petrilla Jayaprakash, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|February 15, 2023
Novel benzothiazole derivatives as multitargeted-directed ligands for the treatment of Alzheimer's diseaseDonia E Hafez, Mariam Dubiel, Gabriella La Spada, et al.
European Journal of Pharmacology|October 5, 2020
Eosinophils adhesion assay as a tool for phenotypic drug screening - The pharmacology of 1,3,5 - Triazine and 1H-indole like derivatives against the human histamine H<sub>4</sub> receptorMarek Grosicki, Maristella Adami, Cristina Micheloni, et al.
Bioorganic & Medicinal Chemistry|April 24, 2018
Novel naphthyloxy derivatives - Potent histamine H<sub>3</sub> receptor ligands. Synthesis and pharmacological evaluationDorota Łażewska, Maria Kaleta, Stefanie Hagenow, et al.
Molecules (Basel, Switzerland)|July 2, 2021
Biphenylalkoxyamine Derivatives-Histamine H<sub>3</sub> Receptor Ligands with Butyrylcholinesterase Inhibitory ActivityDorota Łażewska, Paula Zaręba, Justyna Godyń, et al.
Pageof 4